Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock.
Franz HaertelKarsten LenkMichael FritzenwangerRuediger PfeiferMarcus FranzNedim MemisevicSylvia OttoBernward LauerOliver WeingärtnerDaniel KretzschmarGudrun DannbergJulian WestphalLaura BaezJurgen BogovikuP Christian SchulzeSven Moebius-WinklerPublished in: Journal of clinical medicine (2022)
) 24 h after onset and will provide valuable data for acute interventional strategies or future prospective trials. However, JenaMACS, due to its proof-of-concept design, is limited by its single center protocol, with a small sample size and without a comparison group.